ProCan will analyse tens of thousands of cancer samples from all over the world with the aim of revolutionising cancer diagnosis and treatment.
The team at Children's Medical Research Institute in Sydney is collaborating with researchers around the world.
This ambitious world-first research program aims to analyse the human cancer proteome on an unprecedented scale. ProCan’s primary plans over its expected seven-year initial phase include proteome generation from up to 70,000 cancer samples of all types, from paediatric and adult cancer patients whose treatment outcomes are known. To date, 10,000 samples have been processed. Well-annotated cancer samples are being sourced from collaborators and tissue banks worldwide. Read more.
Dedicated to advancing the treatment and prevention of childhood diseases, so every child has the opportunity for a healthy start to life.
Australian Cancer Research Foundation’s mission is to end cancer by providing scientists with equipment to improve prevention, diagnosis, and treatment of cancer.
The Cancer Institute NSW works across the health care system to promote cancer prevention, early detection, diagnosis and treatment.
SCIEX support the capillary electrophoresis and liquid chromatography-mass spectrometry industry.